BioRestorative Therapies, Inc. (BRTX) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Hungarian Gripen jet crashes, no injuries reported, PM Magyar says
BioRestorative Therapies Inc. (BRTX) PT Raised to $18 at Roth/MKM
August 14, 2024 5:08 AM EDTRoth/MKM analyst Jonathan Aschoff raised the price target on BioRestorative Therapies Inc. (NASDAQ: BRTX) to $18.00 (from $15.00) while maintaining a Buy rating.
The analyst comments "BRTX ended 2Q24 with $14.7M in cash. BRTX is observing encouraging Phase 2 BRTX-100 results, and although still... More
